Search Results - "Mazigi, Ohan"

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants by Tea, Fiona, Ospina Stella, Alberto, Aggarwal, Anupriya, Ross Darley, David, Pilli, Deepti, Vitale, Daniele, Merheb, Vera, Lee, Fiona X. Z, Cunningham, Philip, Walker, Gregory J, Fichter, Christina, Brown, David A, Rawlinson, William D, Isaacs, Sonia R, Mathivanan, Vennila, Hoffmann, Markus, Pöhlman, Stefan, Mazigi, Ohan, Christ, Daniel, Dwyer, Dominic E, Rockett, Rebecca J, Sintchenko, Vitali, Hoad, Veronica C, Irving, David O, Dore, Gregory J, Gosbell, Iain B, Kelleher, Anthony D, Matthews, Gail V, Brilot, Fabienne, Turville, Stuart G

“…The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of…”
Get full text

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies by Schulz, Sebastian R., Hoffmann, Markus, Roth, Edith, Pracht, Katharina, Burnett, Deborah L., Mazigi, Ohan, Schuh, Wolfgang, Manger, Bernhard, Mielenz, Dirk, Goodnow, Christopher C., Christ, Daniel, Pöhlmann, Stefan, Jäck, Hans‐Martin

“…Effective vaccines and monoclonal antibodies have been developed against coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome…”
Get full text

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients by Rouet, Romain, Henry, Jake Y., Johansen, Matt D., Sobti, Meghna, Balachandran, Harikrishnan, Langley, David B., Walker, Gregory J., Lenthall, Helen, Jackson, Jennifer, Ubiparipovic, Stephanie, Mazigi, Ohan, Schofield, Peter, Burnett, Deborah L., Brown, Simon H. J., Martinello, Marianne, Hudson, Bernard, Gilroy, Nicole, Post, Jeffrey J., Kelleher, Anthony, Jäck, Hans-Martin, Goodnow, Christopher C., Turville, Stuart G., Rawlinson, William D., Bull, Rowena A., Stewart, Alastair G., Hansbro, Philip M., Christ, Daniel

“…Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2 monoclonal antibodies and vaccines currently used in clinical…”
Get full text

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies by Rouet, Romain, Mazigi, Ohan, Walker, Gregory J., Langley, David B., Sobti, Meghna, Schofield, Peter, Lenthall, Helen, Jackson, Jennifer, Ubiparipovic, Stephanie, Henry, Jake Y., Abayasingam, Arunasingam, Burnett, Deborah, Kelleher, Anthony, Brink, Robert, Bull, Rowena A., Turville, Stuart, Stewart, Alastair G., Goodnow, Christopher C., Rawlinson, William D., Christ, Daniel

“…Antibodies against coronavirus spike protein potently protect against infection and disease, but whether such protection can be extended to variant…”
Get full text

Protein A superantigen: structure, engineering and molecular basis of antibody recognition by Mazigi, Ohan, Schofield, Peter, Langley, David B, Christ, Daniel

“…Abstract Staphylococcus aureus interacts with the human immune system through the production of secreted factors. Key among these is protein A, a B-cell…”
Get full text

Human genomic DNA is widely interspersed with i-motif structures by Peña Martinez, Cristian David, Zeraati, Mahdi, Rouet, Romain, Mazigi, Ohan, Henry, Jake Y, Gloss, Brian, Kretzmann, Jessica A, Evans, Cameron W, Ruggiero, Emanuela, Zanin, Irene, Marušič, Maja, Plavec, Janez, Richter, Sara N, Bryan, Tracy M, Smith, Nicole M, Dinger, Marcel E, Kummerfeld, Sarah, Christ, Daniel

“…DNA i-motif structures are formed in the nuclei of human cells and are believed to provide critical genomic regulation. While the existence, abundance, and…”
Get full text

Human Antibody Bispecifics through Phage Display Selection by Luthra, Ansha, Langley, David B, Schofield, Peter, Jackson, Jennifer, Abdelatti, Mahmoud, Rouet, Romain, Nevoltris, Damien, Mazigi, Ohan, Crossett, Ben, Christie, Mary, Christ, Daniel

“…We developed a repertoire approach to generate human antibody bispecifics. Using phage display selection of antibody heavy chains in the presence of a…”
Get full text

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia by Aggarwal, Anupriya, Stella, Alberto Ospina, Walker, Gregory, Akerman, Anouschka, Esneau, Camille, Milogiannakis, Vanessa, Burnett, Deborah L., McAllery, Samantha, Silva, Mariana Ruiz, Lu, Yonghui, Foster, Charles S. P., Brilot, Fabienne, Pillay, Aleha, Van Hal, Sabastiaan, Mathivanan, Vennila, Fichter, Christina, Kindinger, Andrea, Hoppe, Alexandra Carey, Munier, Mee Ling, Amatayakul-Chantler, Supavadee, Roth, Nathan, Coppola, Germano, Symonds, Geoff P., Schofield, Peter, Jackson, Jennifer, Lenthall, Helen, Henry, Jake Y., Mazigi, Ohan, Jäck, Hans-Martin, Davenport, Miles P., Darley, David R., Matthews, Gail V., Khoury, David S., Cromer, Deborah, Goodnow, Christopher C., Christ, Daniel, Robosa, Roselle, Starck, Damien J., Bartlett, Nathan W., Rawlinson, William D., Kelleher, Anthony D., Turville, Stuart G.

“…Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged since the start of the COVID-19 pandemic. Over this…”
Get full text

Biocompatibility and Degradation of a Low Elastic Modulus Ti-35Nb-3Zr Alloy: Nanosurface Engineering for Enhanced Degradation Resistance by Mazigi, Ohan, Kannan, M. Bobby, Xu, Jia, Choe, Han-Cheol, Ye, Qingsong

“…In this study, the biocompatibility and degradation behavior of a low elastic modulus Ti-35Nb-3Zr alloy were investigated and compared with that of the…”
Get full text

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies by Rouet, Romain, Mazigi, Ohan, Walker, Gregory J., Langley, David B., Sobti, Meghna, Schofield, Peter, Lenthall, Helen, Jackson, Jennifer, Ubiparipovic, Stephanie, Henry, Jake Y., Abayasingam, Arunasingam, Burnett, Deborah, Kelleher, Anthony, Brink, Robert, Bull, Rowena A., Turville, Stuart, Stewart, Alastair G., Goodnow, Christopher C., Rawlinson, William D., Christ, Daniel

“…Antibodies against coronavirus spike protein potently protect against infection and disease, but whether such protection can be extended to variant…”
Get full text